Revisiting Indications for Brain Imaging During the Clinical Staging Evaluation of Lung Cancer

Revisiting Indications for Brain Imaging During the Clinical Staging Evaluation of Lung Cancer

Introduction: Available guidelines are inconsistent as to whether patients with newly diagnosed clinical stage II NSCLC should receive routine brain imaging. Methods: The National Cancer Database was queried for the prevalence of isolated brain metastases among patients with newly diagnosed NSCLC in...

Full description

Bibliographic Details
Main Authors: Matthew D. Pichert, MD, Maureen E. Canavan, PhD, MPH, Richard C. Maduka, MD, Andrew X. Li, MD, Theresa Ermer, MD, Peter L. Zhan, MD, Michael Kaminski, BA, Brooks V. Udelsman, MD, MHS, Justin D. Blasberg, MD, MPH, Vincent J. Mase, Jr., MD, Andrew P. Dhanasopon, MD, Daniel J. Boffa, MD, MBA
Format: Article
Language:English
Published: Elsevier 2022-05-01
Series:JTO Clinical and Research Reports
Subjects:
Non–small cell lung cancer
Brain imaging
Indications
Brain MRI
Online Access:http://www.sciencedirect.com/science/article/pii/S266636432200042X

Similar Items

Similar Items